ArticleVaccines2024

Retrospective, Observational Analysis on the Impact of SARS-CoV-2 Variant Omicron in Hospitalized Immunocompromised Patients in a German Hospital Network-The VISAGE Study.

Irit Nachtigall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.